由快速起作用的抗抑郁药干预引起的结构神经可塑性
Clara Liao1,2, Alisha N Dua3, Cassandra Wojtasiewicz1
1Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA.
Nature reviews. Neuroscience
|November 18, 2024
概括
快速起作用的抗抑郁药物,如胺,通过促进大脑中树突性脊柱的生长来增强神经可塑性. 这种结构性重新连接为治疗严重抑郁症 (MDD) 提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 细胞生物学 细胞生物学
背景情况:
- 大型抑郁症 (MDD) 涉及到前额叶皮层激发性突触受损.
- 快速抗抑郁药物治疗 (胺,ECT,神经刺激) 一致增强神经可塑性.
- 将治疗与突触恢复联系起来的特定可塑性机制尚不清楚.
研究的目的:
- 审查关于精神活性药物和其他干预措施如何影响神经元结构的临床前证据.
- 确定与结构可塑性相关的快速起作用抗抑郁药的特征.
- 探索突触重塑在理解抗抑郁药机制中的作用.
主要方法:
- 在过去15年中对临床前研究进行了回顾.
- 各种精神活性药物对神经元重新连接的纵向影响的比较.
- 对药物引起的体内结构可塑性的分析.
主要成果:
- 胺和迷幻药物刺激皮质金字塔神经元中的树突脊柱生长.
- 迅速开始和持续的效果是有效的抗抑郁药干预的关键特征.
- 结构性可塑性为理解各种抗抑郁药的作用提供了一个框架.
结论:
- 结构性神经可塑性,特别是树突性脊柱生长,是快速起作用抗抑郁药的关键机制.
- 突触重塑为精神活性药物和抗抑郁药物干预的神经生物学提供了关键的见解.
- 对药物引起的结构可塑性的进一步研究可以指导开发新型MDD治疗方法.
相关概念视频
Neuroplasticity
302
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
302
Antidepressant Drugs: MAOIs and Other Agents
195
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
195
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
316
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
316
Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K
Antidepressant Drugs: Overview
365
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
365


